Arcoma

Arcoma EPS Growth

The EPS Growth of Arcoma (ARCOMA.ST) as of Oct 26, 2026 is -58.54 %. In the previous year, EPS Growth was 340.46 % — a change of -117.19% (lower).

EPS Growth

-58.54 %

YoY

-117.19%

Last updated:

EPS Growth of Arcoma is 2025 -58.54 % . EPS Growth of Arcoma was 2024 340.46 % . It decreases by -117.19% lower compared to the previous year.

The Arcoma EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2018
83.85 SEK
Jan 1, 2019
516.77 SEK
Jan 1, 2020
-79.57 SEK
Jan 1, 2021
-640.62 SEK
Jan 1, 2022
124.98 SEK
Jan 1, 2023
33.44 SEK
Jan 1, 2024
340.46 SEK
Jan 1, 2025
-58.54 SEK
The Arcoma EPS Growth history
YEAREPS GrowthYoY
-58.54 %-117.19%
340.46 %+918.15%
33.44 %-73.24%
124.98 %-119.51%
-640.62 %+705.12%
-79.57 %-115.40%
516.77 %+516.31%
83.85 %+170.40%
31.01 %-104.15%
-747.44 %-7.22%
-805.58 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

EPS Growth of Arcoma is -58.54 % in 2025.

On Eulerpool you can find the complete historical development of EPS Growth Arcoma since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's Arcoma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Arcoma

All Key Metrics — Arcoma